Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex

Experimental Neurology

Volumn 167, Issue 1, 2001, Pages 158-165

  Lian, Qingyu ^a   Ladner, Christopher J ^a   Magnuson, Debra ^a   Lee, John M ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Alzheimer's disease; Calcineurin; Neurodegeneration; Neurofibrillary tangle; Tau

Indexed keywords

CALCINEURIN; CYCLOPHILIN A; NICKEL; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CELL FREE SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENILE PLAQUE; SENSORIMOTOR CORTEX;

EID: 0035155854     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7534     Document Type: Article

References (39)

1. The structure of the B subunit of calcineurin
2. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5
3. Calcineurin immunoreactivity in Alzheimer's disease
4. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
5. Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease
6. Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle
7. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A
8. Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid
9. Tau phosphorylation in brain slices: Pharmacological evidence for convergent effects of protein phosphatases on tau and mitegen-activated protein kinase
10. Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease
11. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheireef's disease
12. Phosphatase activity toward abnormally phosphorylated tau: Decrease in Alzheimer disease brain
13. Phosphoprotein phosphatase activities in Alzheimer disease brain
14. Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin)
15. Caicineurin in human brain and its relation to extrapyramidal system; Immunohistochemical study on postmortem human brains
16. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology
17. Resolution of bovine brain calcineurin subunits: Stimulatory effect of subunit B on subunit A phosphatase activity
18. Okadaic acid induces hyperphosphorylated forms of tau pretein in human brain slices
19. Extracellular signal regulated kinases: Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease
20. Defective brain microtubule assembly in Alzheimer's disease
21. PKA-dependant phosphorylations of tau and cAMP-regulated proteins in Alzheimer's disease
22. Cytoskeletal changes in the brains of mice lacking calcineurin A alpha
23. Activation of calcineurin by nickel ions
24. Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein
25. Calcineurin
26. Reduction of calcineurin enzymatic activity in Alzheimer's disease: Correlation with neuropathologic changes
27. Activation of brain calcineurin phosphatase towards nonprotein phosphoesters by Ca2+, calmodulin, and Mg2+
28. Tau domains, phosphorylation, and interactions with microtubules
29. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
30. Demonstration of different metal ion-induced calcineurin conformations using a monoclonal antibody
31. Calmodulin-dependent protein phosphatase: Isolation of subunits and reconstitution to holoenzyme
32. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease
33. Calmodulin antagonists differentiate between Ni(2+)- and Mn(2+)-stimulated phosphatase activity of calcineurin
34. Calmodulin-stimulated dephosphorylation of p-nitrophenyl phosphate and free phosphotyrosine by calcineurin
35. Expression of protein phosphatases (PP-1, PP-2A, PP-2B, and PTP-1B) and protein kinases (MAP kinase and P34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals
36. Detection of Alzheimer type pathological epitopes on Tau proteins of neuroblastoma cells after treatment with okadaic acid
37. Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules
38. Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3
39. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B